SCHEMBL23094264

SCHEMBL23094264

COc1ccccc1C/C(N)=N/OC(=O)COc1ccc(Br)c(C)c1

nearest known ligand 0.74

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.74
▸ HTT P42858 1/20 0.74
▸ L3MBTL1 Q9Y468 9/20 0.73
▸ SMN1; SMN2 Q16637 1/20 0.73
▸ TDP1 Q9NUW8 8/20 0.70
▸ MAPK1 P28482 3/20 0.66
▸ MEN1 O00255 2/20 0.60
▸ KMT2A Q03164 2/20 0.60
▸ ALDH1A1 P00352 1/20 0.60
▸ HPGD P15428 1/20 0.60
▸ CYP1A2 P05177 2/20 0.53
▸ CYP3A4 P08684 2/20 0.53
▸ CYP2C19 P33261 2/20 0.53
▸ KDM4E B2RXH2 1/20 0.53
▸ POLB P06746 1/20 0.50
▸ RECQL P46063 1/20 0.50
▸ CYP2D6 P10635 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23094169 0.86 MAPT (0.81) MAPTHTTL3MBTL1SMN1; SMN2TDP1
SCHEMBL23094183 0.85 MAPT (0.73) MAPTHTTL3MBTL1SMN1; SMN2TDP1
SCHEMBL23094234 0.85 MAPT (0.76) MAPTHTTL3MBTL1SMN1; SMN2TDP1
SCHEMBL2182563 0.85 MAPT (1.00) MAPTHTTL3MBTL1SMN1; SMN2TDP1
SCHEMBL2182559 0.85 MAPT (1.00) MAPTHTTL3MBTL1SMN1; SMN2TDP1
SCHEMBL23094257 0.84 MAPT (0.63) MAPTHTTL3MBTL1SMN1; SMN2TDP1
SCHEMBL21467841 0.84 L3MBTL1 (1.00) MAPTHTTL3MBTL1SMN1; SMN2TDP1
SCHEMBL23094216 0.83 TDP1 (0.67) MAPTHTTL3MBTL1SMN1; SMN2TDP1
SCHEMBL23094164 0.82 TDP1 (1.00) MAPTHTTL3MBTL1SMN1; SMN2TDP1
SCHEMBL23094242 0.82 MAPT (0.72) MAPTHTTL3MBTL1SMN1; SMN2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10947188-B2 Small molecule ferroptosis inducers THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2021-03-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10947188-B2 Small molecule ferroptosis inducers GPX4, AIFM2, GPX1 MAPT 4344/4885HTT 3066/4885L3MBTL1 2077/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback